Why the study?
Does potassium, glucose and insulin (PGI) therapy improve electrocardiographic signs in clinical subjects with myocardial infarction and ischaemia?
Does potassium, glucose and insulin (PGI) therapy improve electrocardiographic signs in clinical subjects with myocardial infarction and ischaemia?
This study aimed to evaluate whether potassium, glucose, and insulin therapy resolves ECG signs of myocardial infarction, though results are not available in the truncated abstract.
Answers are grounded in this paper and cite their sources.
PGI therapy improves ECG signs in MI; extends metabolic modulation evidence for acute ischemia.
DECREASE in intracellular potassium concentra-tion with simultaneous increase in the concentra-tions of sodium, chloride and water as a result of myocardial ischaemia (Dennis & Moore, 1938; Jennings et al., 1957; Russell et al., 1961; Prior-eschi, 1963) is believed to be responsible for electrocardiographic (ECG) alterations in cardiac infarction (Gubner & Behr, 1957; Cummings, 1960; Prinzmetal et al., 1961, 1962). Hypopolari-zation of the myocardial cell, caused by these electrolytic alterations, results in reduction of its resistance so that the cell is more liable to act as an irritable focus. Cardiac arrhythmias, generated in this way, account for the majority of deaths in acute myocardial infarction (Julian et al., 1964; Goble et al., 1966). Sodi-Pallares et al. (1962a) observed restitution of intracellular potassium concentration, diminu-tion in injury current as recorded on the ECG, and diminished excitability of the myocardium following the use of potassium, glucose and insulin (PGI) therapy in experimental cardiac infarcts. This regimen has already been shown to be cap-able of causing significant reduction in mortality in patients with myocardial infarction (Mittra, 1965), mainly by preventing deaths due to arrhy-thmias (Mittra, 1967). The close relationship between improvement in biochemical abnormality at the myocardial cellu-lar level and the resolution of ECG changes of infarction provided an opportunity to test the efficacy of PGI therapy in clinical subjects with myocardial infarction and ischaemia by measur-ing the improvement on the ECG and comparing it with the progress of other patients acting as controls. Material and methods The subjects of the present study belonged to the treated and control groups of a clinical trial which was designed to test the efficacy of PGI therapy in myocardial infarction. The criteria for diagnosis of infarction, details of the regimen and the results obtained in the trial have been
No takes yet. Share an insight, caveat, or question.
B Mittra (1967) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: